Genomics in the news
Genomics' work on preventing premature mortality in The Financial Times
26 Nov 2024
The Financial Times covered our latest ground-breaking research, showing that gene screening can cut early disease deaths by 25%. A simple genetic screening test has the potential to stop almost a quarter of premature preventable deaths from common diseases including breast cancer, diabetes and hypertension, by identifying those most at risk.
New research from Genomics and Stanford Medicine indicates polygenic risk score screening could prevent almost a third of premature, preventable deaths
26 Nov 2024
Our research shows very high risk individuals reached the risk levels associated with usual starting screening ages 12.4 years earlier, on average. In other words, if a screening programme were devised on the basis of the average risk facing a 50-year-old, this high risk group would have the same predicted risk at the age of 37.6. Recommendations for earlier screening for genetically very high risk groups ranged from four years in advance for abdominal aortic aneurysm, to 22 years for hypertension.
Genomics' work on obesity in The Telegraph
19 Nov 2024
The Telegraph covered our latest study on obesity, which showed that individuals with a genetic risk score for high BMI, calculated using Genomics’ proprietary polygenic risk scores (PRS), were 10 times more likely to develop obesity later in life - even at the same activity levels and calorie intake.
ASHG 2024: New study from Genomics indicates individuals who have a genetic predisposition for high BMI may require tailored approaches to tackle obesity
12 Nov 2024
Our research shows that those at high genetic risk of obesity will need personalised support to help them stay at, or return to, a healthy weight.
Genomics releases new research showing significant link between genetic risk and obesity
16 Oct 2024
Genomics releases new research showing significant link between genetic risk and obesity
Genomics Announces David Thornton as President
30 Sep 2024
Genomics announces the appointment of David Thornton to the position of President, succeeding Professor Gil McVean, who will join the board as a non-executive Director.
Genes in 8% of population found to raise heart disease risk
19 Sep 2024
The Times covers a new study that has claimed that thousands of heart attacks and strokes could be prevented by incorporating people’s genetic risk into their standard middle-aged health check. Researchers have identified a suite of genetic changes, affecting 1 in 12 Britons, that significantly raise the chance of suffering heart disease.
Why health systems are buying into genomics
17 Sep 2024
Mount Sinai Health System is launching a center that will conduct genetic-based research on undiagnosed medical conditions. The system's Center for Undiagnosed Diseases will open early next year, the latest evidence of the money providers are pouring into genomics. Mount Sinai said Tuesday the center will be home to New York City's first undiagnosed disease network, which connects clinicians across the U.S. conducting this kind of research.
Genetic Risk Testing - Policyholder Misconceptions and Benefits to Insurers
15 Aug 2024
As the conversation around genetic risk testing continues to evolve, it's crucial to address the misconceptions that surround it. This latest article by Genomics' Co-Founder and CEO, Sir Peter Donnelly, discusses the common misunderstandings around genetic risk testing and the untapped benefits it holds for the insurance industry.
Genomics Announces New Extension and Expansion of Drug Discovery Collaboration with Vertex
17 Jul 2024
The three-year extension expands the range of therapeutic areas and genomic data insights and also explores the use of genomic risk to better define patient subgroups